Nexeon MedSystems, Inc. announced that it will receive $2,000,000 in funding on April 21, 2017. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The minimum investment accepted from any outside investor is $10,000. The company will provide an over-allotment option for an amount of $500,000.